PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Synamatix

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Synamatix Announces SynaWorks – A Next-generation Sequencing Bioinformatics Solutions Programme - Synamatix announced today the release of SynaWorks, its new bioinformatics solutions programme for handling data from next generation DNA sequencers
Synamatix Announces SynaWorks – A Next-generation Sequencing Bioinformatics Solutions Programme

 

NewswireToday - /newswire/ - Kuala Lumpur, Malaysia, 2008/06/24 - Synamatix announced today the release of SynaWorks, its new bioinformatics solutions programme for handling data from next generation DNA sequencers.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Synamatix announced today the release of SynaWorks, its new next-generation bioinformatics solutions programme. SynaWorks is a comprehensive suite of bioinformatics applications specifically tailored to manage and leverage data generated from a variety of next-generation sequencers.

Users will be able to take advantage of integrated bioinformatics applications that process, analyse, mine, assemble and visualise data from experiments such as whole-genome resequencing, transcriptome sequencing, ChIP-seq and de novo genome sequencing. Particular emphasis will be placed on helping researchers analyse data rapidly to identify and prioritise biologically significant findings.

Synamatix has optimised its solutions to handle a variety of data set types generated from the Roche Genome Sequencer FLX, Illumina’s Genome Analyzer and the SOLiD system from ABI. According to Synamatix General Manager, Dr Arif Anwar, “The aim of SynaWorks is to provide a comprehensive solution to scientists by managing and leveraging the huge amounts of DNA data generated from next-generation sequencers. We can assist with project design, provide bioinformatics know-how, analyse data according to individual requirements and, most importantly, work with researchers to help achieve meaningful scientific findings.”

While most solution providers mainly focus on handling genomics data, which includes moving, storing and archiving, Synamatix takes a different approach by offering a data analysis pipeline and platform that helps researchers maximise their research findings through data mining and visualisation.

About Synamatix
The fundamental technology underlying Synamatix R&D is the proprietary “SynaBASE” platform. Applications built upon this database platform exhibit significant improvement in analysis scalability, sensitivity and performance. Synamatix (synamatix.com) is a privately held bioinformatics company whose primary activities are ongoing R&D related to its core technology, and the support of its user base in the USA, Europe, Asia and Australia.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Synamatix

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Synamatix Announces SynaWorks – A Next-generation Sequencing Bioinformatics Solutions Programme

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Patricia Chan - Synamatix.com 
+603-22545676 enquiries[.]synamatix.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Synamatix securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Synamatix / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)